Chemoproteomics-enabled identification of the targets of a hydroxylated cholesterol metabolite, 20(S)-hydroxycholesterol, reveals it to be the first reported endogenous ligand of the sigma-2 receptor, a drug target for neurodegeneration and neuropathic pain.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Luu, W., Sharpe, L. J., Capell-Hattam, I., Gelissen, I. C. & Brown, A. J. Annu. Rev. Pharmacol. Toxicol. 56, 447–467 (2016).
Radhakrishnan, A., Ikeda, Y., Kwon, H. J., Brown, M. S. & Goldstein, J. L. Proc. Natl Acad. Sci. USA 104, 6511–6518 (2007).
Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J. & Russell, D. W. Cell Metab. 5, 73–79 (2007).
Nachtergaele, S. et al. Nat. Chem. Biol. 8, 211–220 (2012).
Cheng, Y.-S. et al. Nat. Chem. Biol. 17, https://doi.org/10.1038/s41589-021-00907-2 (2021).
Matsumoto, R. R., Bowen, W. D. & Su, T. P. Sigma Receptors (Springer, 2007).
Alon, A. et al. Proc. Natl Acad. Sci. USA 114, 7160–7165 (2017).
Alon, A. et al. Preprint at https://doi.org/10.1101/2021.04.29.441652 (2021).
Bartz, F. et al. Cell Metab. 10, 63–75 (2009).
Jumper, J. et al. Nature 596, 583–589 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Yu, W., Baskin, J.M. There is a lock for every key. Nat Chem Biol 17, 1214–1216 (2021). https://doi.org/10.1038/s41589-021-00908-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-021-00908-1